Piscataway, NJ, February 11, 2016– Camber Pharmaceuticals announces that it has launched Tetrabenazine 12.5mg and 25mg tablets. The drug is the generic version of Xenazine® tablets. Tetrabenazine is used to treat involuntary movements (chorea) in patients with Huntington’s disease.
Tetrabenazine is available in 112 count for both 12.5mg and 25mg.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at firstname.lastname@example.org.